Company Valuation: Immunovia AB

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2024 2025 2026 2027 2028
Market Cap 1 1,697 595.2 92.66 152.7 117.7 - -
Change - -64.93% - 64.79% -22.91% - -
Enterprise Value (EV) 1 1,443 526.7 92.66 76.09 50.72 43.72 99.72
Change - -63.5% - -17.88% -33.35% -13.8% 128.1%
P/E -0.11x -0.04x -0.01x -0.54x -1.75x -4.38x -8.75x
PBR 0.04x 0.02x - - - - -
PEG - -0.01x - 0x 0x 0.1x 0.2x
Capitalization / Revenue 1,775x 494x - 203x 36.8x 6.8x 2.14x
EV / Revenue 1,510x 437x - 101x 15.8x 2.53x 1.81x
EV / EBITDA -9.78x -3.17x - -0.97x -0.57x -0.55x -2.12x
EV / EBIT -8.66x -2.76x - -0.95x -0.56x -0.53x -1.99x
EV / FCF -9.27x -2.97x - -0.91x -0.54x -0.5x -1.78x
FCF Yield -10.8% -33.6% - -110% -185% -199% -56.2%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -689 -743 -93 -0.42 -0.1 -0.04 -0.02
Distribution rate - - - - - - -
Net sales 1 0.956 1.204 - 0.752 3.2 17.3 55
EBITDA 1 -147.6 -166.2 - -78.06 -89 -80 -47
EBIT 1 -166.6 -191.2 - -80.38 -91 -82 -50
Net income 1 -156 -168.1 -76.54 -145.9 -91 -82 -50
Net Debt 1 -254.1 -68.47 - -76.6 -67 -74 -18
Reference price 2 75.0000 26.3000 0.5460 0.2270 0.1750 0.1750 0.1750
Nbr of stocks (in thousands) 22,632 22,632 169,711 672,667 672,667 - -
Announcement Date 2/17/22 2/23/23 2/25/25 2/24/26 - - -
1SEK in Million2SEK
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
60.88x4.61x15.45x0.36% 15.54B
38.39x - - 2.11% 1.65B
-10.03x1.28x5.61x-.--% 1.09B
15.99x2.25x7.53x1.47% 948M
49.42x - - 0.91% 505M
46.97x - - - 460M
17.87x2.51x10.73x1.91% 365M
24.01x4.07x13.86x1.96% 344M
Average 30.44x 2.94x 10.64x 1.24% 2.61B
Weighted average by Cap. 51.42x 4.23x 14.32x 0.6%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA